We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:NTLA
​
​
logo

Intellia Therapeutics (NTLA)

Nasdaq • NTLA • US45826J1051

12.31Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 20, 2026, ORTEX estimates 34% of free float is sold short, 7.7 days to cover, cost to borrow 0.45%.

Market Cap

1.72b USD | # 4174 in US

Volume

4.35m shares | 52.38m USD

Shares Outstanding

140.13m

Free Float Shares

95.78% | 134.21m

DB:38I|
LSE:0JBU

News

NTLA key data

Intellia Therapeutics (Nasdaq: NTLA) has a market capitalization of $1.72B. Last close $12.31 (as of 2026-11-05); 52-week range $7.95 to $18.48. ORTEX data as of 2026-10-20: short interest is 33.97% of free float, 7.7 days to cover and the average cost to borrow is 0.45%.

Latest on NTLA

  • May 13, 2026NTLA Heads Into Earnings With One-Third of Float Sold Short
All NTLA news on ORTEX News
  • NTLA news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.